Novo Nordisk's Q4 results hinge on Ozempic and Wegovy sales as demand growth slows amid guidance cuts due to intense rivalry and compounded drug headwinds.

Novo Nordisk's Wegovy pill was prescribed more than 18,000 times in the U. in the first full week after its launch in an ...

As GLP-1 pills for weight loss enter the U.S. market, some pharmaceutical companies are testing the possibility of a gene therapy to stimulate GLP-1 production, The Washington Post reported Jan. 24.

The source of this renewed optimism lies in concrete figures related to the U.S. launch of the oral Wegovy variant in January 2026. Market observers believe the daily pill could be a decisive factor ...

IF you are a parent and wondering how you can trade bullying, burnout and broken systems for curiosity, confidence and ...

However, not everyone is willing—or able—to indefinitely commit to GLP-1s.

ETHealthworld.com brings latest marion biotech news, views and updates from all top sources for the Indian Health industry.

Tirzepatide users on hormone therapy had added improvements in weight, cardiometabolic mar ...

Once known for bottomless breadsticks and supersized meals, American chain restaurants are increasingly rethinking their portion sizes. As GLP-1 weight-loss medications like Ozempic, Wegovy and ...

A once-weekly injectable glucose-dependent insulinotropic polypeptide/GLP-1 dual agonist conferred up to 14.7% weight loss at ...

Higher-income households with at least one user of GLP-1 class of weight loss drugs cut their grocery spending by nearly 9%, a recent study based on data from the market research firm Numerator ...

Is Obesity Genetic or Environmental? Get All the Details This article was reviewed by Lynn Marie Morski, MD, JD. Key ...